SIROLIMUS延缓衰老雷帕霉素(西罗莫司)免疫抑制剂

SIROLIMUS延缓衰老雷帕霉素(西罗莫司)免疫抑制剂

SIROLIMUS延缓衰老雷帕霉素(西罗莫司)免疫抑制剂，日语中也称为 ラパリムス錠 1mg是一种口服处方药，含有 西罗莫司 1mg西罗莫司，在研究文献中也被广泛称为雷帕霉素，是一种 mTOR抑制剂 在专业医疗监督下使用。

RAPALIMUS 1mg 片剂由日本 Nobelpharma Co., Ltd.（诺贝尔制药株式会社）生产并销售。每片含有 1mg 西罗莫司。该产品为口服片剂，仅限凭处方使用。

产品信息：

• 产品名称： SIROLIMUS延缓衰老雷帕霉素(西罗莫司)免疫抑制剂
• 日文名称： ラパリムス錠 1mg
• 通用名称： Sirolimus Tablets 1mg
• Research Name: Rapamycin Tablets 1mg
• 中文名称： 雷帕立慕斯錠 1mg / 西羅莫司片 1mg
• 活性成分： 西罗莫司
• Japanese Ingredient: シロリムス
• 强度: 1mg per tablet
• Package Size: 30片
• 剂型： 药片
• 路线 口服
• 药物类别： mTOR inhibitor / immunosuppressive agent
• 制造商： Nobelpharma Co., Ltd.
• 日本制造商： ノーベルファーマ株式会社
• 使用级别：处方药 / 需在专业医疗监督下使用

什么是雷帕利莫司（RAPALIMUS）1毫克片剂？

RAPALIMUS 1mg 片剂含有西罗莫司（一种 mTOR 抑制剂）。mTOR 通路参与细胞生长、增殖、代谢及免疫调节过程。通过抑制 mTOR 信号传导，西罗莫司能够在特定医学状况下调节免疫及细胞活性。

在日本，拉帕利姆斯（Rapalimus）片（1mg）用于淋巴管平滑肌瘤病以及某些难治性血管或淋巴系统疾病等专业医疗领域。治疗应始终在具备相应资质的医疗专业人员指导下进行，并根据需要对临床疗效、安全性和血药浓度进行适当监测。

主要优点

• Contains sirolimus 1mg per tablet
• mTOR inhibitor with immunomodulating activity
• Used under specialist medical supervision
• Associated with treatment of lymphangioleiomyomatosis
• Associated with treatment of certain refractory lymphatic or vascular diseases
• 口服片剂
• Manufactured by Nobelpharma Co., Ltd. in Japan
• Prescription-use medicine requiring clinical monitoring

适应症和用途

This product is generally associated with professional medical treatment for:

• Lymphangioleiomyomatosis, also known as LAM
• Refractory lymphatic diseases
• Lymphangioma / lymphatic vascular malformation
• Lymphangiomatosis
• Gorham disease
• Lymphangiectasia
• Refractory vascular tumors and vascular malformations, where clinically appropriate
• Specialist immunomodulatory treatment under medical supervision

Use must follow the official prescribing information, physician assessment, patient condition, and applicable local regulations. This product should not be used for self-medication.

Research and Anti-Aging Interest

Sirolimus / rapamycin has attracted scientific and public attention because of its role in the mTOR pathway, a pathway involved in metabolism, cellular growth, and aging-related research. It has also been discussed in longevity-related media and documentaries, including public interest around biohacking and longevity figures.

However, anti-aging or longevity use is not the same as an approved medical indication. This product should not be presented as a guaranteed anti-aging medicine, longevity supplement, beauty product, or wellness supplement. Any off-label consideration must be discussed with a qualified healthcare professional.

剂量和用法

• This product is taken orally.
• Use only as prescribed by a qualified healthcare professional.
• Dosage depends on the patient’s diagnosis, body surface area, clinical condition, treatment response, and blood trough concentration where applicable.
• For lymphangioleiomyomatosis, a commonly referenced adult dosage is sirolimus 2mg once daily, adjusted according to patient condition, with a maximum of 4mg once daily.
• For refractory lymphatic disease, the starting dose may vary according to body surface area, with subsequent adjustment based on blood trough concentration and clinical response.
• Take consistently at the same time each day unless otherwise directed by a healthcare provider.
• Do not start, stop, increase, reduce, or change the dosing schedule without medical advice.

Important Use Clarification

RAPALIMUS TABLETS 1MG is a prescription mTOR inhibitor medicine. It is not a dietary supplement, not a general anti-aging supplement, not a cosmetic medicine, not a skin booster, not a dermal filler, not a water-light injection, and not a weight management product.

防范措施

• Prescription medicine; use only under medical supervision.
• Not suitable for self-medication or unsupervised longevity use.
• Do not use if allergic to sirolimus, rapamycin, or any component of the product.
• Use caution in patients with liver dysfunction, infection, lung disease, kidney problems, abnormal lipid levels, diabetes, poor wound healing, or immunocompromised conditions.
• May increase susceptibility to infections due to immunosuppressive effects.
• Vaccination plans should be discussed with a healthcare provider.
• Pregnant or breastfeeding individuals should consult a healthcare provider before use.
• Regular blood tests and clinical monitoring may be required.
• Blood trough concentration monitoring may be required depending on indication and physician instructions.
• Inform your healthcare provider about all medicines, supplements, and herbal products before use.

可能的副作用

可能出现的副作用包括：

• Mouth ulcers or stomatitis
• Rash or acne-like skin symptoms
• 腹泻
• 恶心或胃肠道不适
• 头痛
• Swelling or edema
• Increased blood lipid levels
• Delayed wound healing
• Increased risk of infection
• Abnormal blood test results

Serious but less common risks may include severe infection, interstitial lung disease or lung inflammation, kidney-related problems, liver function abnormalities, severe allergic reaction, blood disorders, or serious metabolic abnormalities. Seek medical attention immediately if symptoms such as fever, persistent cough, shortness of breath, chest pain, severe rash, unusual bleeding, severe mouth ulcers, swelling, or signs of infection occur.

药物相互作用

Sirolimus may interact with various medicines and substances. Patients should inform their healthcare provider about all prescription medicines, over-the-counter medicines, supplements, herbal products, and dietary habits. Some medicines may increase or decrease sirolimus blood levels, affecting safety and effectiveness.

Do not combine with other medicines or supplements without professional advice.

贮存

• Store according to the official product packaging or prescribing information.
• Keep away from direct sunlight, heat, and moisture.
• Store in the original package until use.
• 请将本品放在儿童不能接触的地方。
• Do not use after the expiry date printed on the packaging.

Package Contents

• SIROLIMUS延缓衰老雷帕霉素(西罗莫司)免疫抑制剂
• 30 tablets per box
• Each tablet contains sirolimus 1mg

重要免责声明

This product information is provided for general product reference and SEO description purposes only. It does not replace professional medical advice, diagnosis, treatment, official prescribing information, or product labeling. RAPALIMUS TABLETS 1MG should be used only under the supervision of a qualified healthcare professional according to applicable medical standards and local regulations.